Mississippi 2024 Regular Session

Mississippi Senate Bill SB2370

Introduced
2/12/24  
Refer
2/12/24  

Caption

Uniform Controlled Substances Act; include certain substances within Schedule III.

Impact

The inclusion of Mitragynine and 7-Hydroxymitragynine in Schedule III means that their manufacturing, distribution, and consumption will be subject to stricter regulations. This change could have significant implications for those involved in the herbal supplement industry and potential users who may rely on these substances for medicinal purposes. They will require prescriptions for legal access, which may limit availability and create barriers for individuals who use these substances for legitimate reasons, such as managing chronic pain or opioid withdrawal symptoms. Furthermore, the bill may lead to increased enforcement and legal ramifications for possession and distribution.

Summary

Senate Bill 2370 seeks to amend the Mississippi Code of 1972 by including Mitragynine and 7-Hydroxymitragynine as Schedule III controlled substances. These compounds, derived from the Kratom plant, are often used for pain relief and have gained popularity for their psychoactive effects. The bill's supporters argue that this amendment is necessary to regulate the use of these substances, which they believe pose risks of addiction and misuse among consumers. By reclassifying these substances, the legislature aims to create a safer environment for individuals who use or are vulnerable to drugs derived from natural sources.

Contention

During discussions around SB 2370, notable points of contention emerged regarding the potential impact on users and the herbal supplement market. Advocates for the plant-based wellbeing industry criticized the decision to classify these naturally derived compounds as controlled substances, arguing this could pave the way for increased criminalization and decrease access among legitimate users. Conversely, proponents of the bill maintain that the classification is vital for public health, ensuring that potentially harmful substances are monitored. The balance between regulation and accessibility remains a pivotal discussion point as the legislature considers this significant amendment.

Companion Bills

No companion bills found.

Similar Bills

MS HB4

Tianeptine; include in Schedule I controlled substance list.

MS SB2355

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS HB1121

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS SB2214

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS HB1038

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS HB1122

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

VA SB614

Xylazine; penalty for manufacturing, selling, etc., for human consumption.

VA HB1187

Xylazine; penalty for manufacturing, selling, etc., for human consumption.